Headed for a cliff

Discussion in 'Biohaven' started by anonymous, Apr 13, 2020 at 1:13 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    that’s a bad gross to net. Need to ease up on the full buy down for Rx’s: not only is it expensive, you also have to pay fee to the agency that processes the copay discount. Gets very expensive.
     

  2. anonymous

    anonymous Guest

    How about those earnings! Only lost $270m in q2.
     
  3. anonymous

    anonymous Guest

    Sorry. Typo. $-210m
     
  4. anonymous

    anonymous Guest

    So?
     
  5. anonymous

    anonymous Guest

    new companies in debt really like to see the trajectory arrow go UP instead of DOWN..next...
     
  6. anonymous

    anonymous Guest

    Shitty company. It’s downhill for almost all of them. Adios….
     
  7. anonymous

    anonymous Guest

    Company is shitty from the top down. What do you expect with BJ running the show?
     
  8. anonymous

    anonymous Guest

    Please. We all need a BJ in our life.
     
  9. anonymous

    anonymous Guest

    Sorry you couldn’t make it here. I know it’s tough out there, but you’ll be okay.
     
  10. anonymous

    anonymous Guest

    Your comment didn't hold up to well.
     
  11. anonymous

    anonymous Guest


    You comment is now living proof that turds who know nothing are rampant on cafepharma.
    Huge upside...Nurtec now no1 in CGRP. Profits going up up up.
     
  12. anonymous

    anonymous Guest

    And stock going DOWN, DOWN, DOWN! Spending exceeding profits at record pace.
     
  13. anonymous

    anonymous Guest

    That’s because our selfish self righteous managers are siphoning off profits and bonuses faster than they’re coming in
     
  14. anonymous

    anonymous Guest

    and my bank account will soon be going up up up